influenza mRNA vaccine (Stemirna Therapeutics)

N/A

Report date: 2026/01/23 11:09:03

Base Information

Drug Nameinfluenza mRNA vaccine (Stemirna Therapeutics)
Drug Alias Nameinfluenza mRNA vaccine (Stemirna Therapeutics)influenza mRNA vaccine(Stemirna Therapeutics)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesStemirna Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStemirna Therapeutics
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A